Stay updated with breaking news from Adrian Ebner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Three leading U.S. interventional cardiologists attend initial cases as company prepares to expand its clinical programLOS GATOS, Calif., Sept. 1...
Supira Medical announced today that it initiated the first-in-human clinical study of its percutaneous ventricular assist device (pVAD).
This article examines the need to conduct medtech clinical trials outside the U.S. and explores the growth of these trials in Latin America,...
Artio Medical Announces Successful First Human Use of the Amplifi™ Vein Dilation System First-of-its-kind medical device aims to improve vascular access for hemodialysis patients News provided by Share this article Share this article PRAIRIE VILLAGE, Kan., Jan. 27, 2021 /PRNewswire/ -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today that it has successfully completed the first human use of its Amplifi ™ Vein Dilation System. The first clinical procedure was performed by A...
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Two CoreoGraft Patients Have Reached 30 Day Milestone IRVINE, CA / ACCESSWIRE / December 16, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that two patients who have undergone heart bypass surgeries utilizing HJLI's CoreoGraft have reached the 30-day milestone and are reported to have good cardiac function. The first two CoreoGraft surgeries were completed in late October and early November, respectively. CoreoGraft patients undergo electro...